No Data
No Data
Is Acasti Pharma (ACST) Outperforming Other Medical Stocks This Year?
H.C. Wainwright Maintains Acasti Pharma(ACST.US) With Buy Rating, Maintains Target Price $12
Strong Buy: Acasti Pharma's GTX-104 Poised for Standard of Care in ASAH With Promising Market Outlook
Craig-Hallum Maintains Acasti Pharma(ACST.US) With Buy Rating, Maintains Target Price $6
Express News | Acasti Pharma Inc: Anticipate Staying on Track for a Potential Nda Submission to FDA in First Half of Calendar 2025
Express News | Acasti Pharma Inc: Anticipate Randomizing All 100 Patients in Late 2024 to Early 2025
BarfBag : Add $Cybin (CYBN.US)$ and $Vintage Wine Estates (VWE.US)$ to that list
BullRunner : Do you guys do Foreign stocks?